DR info

臨床試験数 : 20 / 薬物数 : 39 - (DrugBank : 13) / 標的遺伝子数 : 6 - 標的パスウェイ数 : 18

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

30-hour ambulatory sampling of intestinal fluid
   University of Bergen
      2018   -   NCT03793114   Germany;Norway;Sweden;
Betamethasone
   Göteborg University
      2021   Phase 4   NCT03210545   Sweden;
Cortef (hydrocortisone)
   Haukeland University Hospital
      2010   Phase 2/Phase 3   NCT01063569   Norway;Sweden;
Cosyntropin
   University of Bergen
      2018   -   NCT03793114   Germany;Norway;Sweden;
Dehydroepiandrosterone
   National Center for Research Resources (NCRR)
      1995   Phase 3   NCT00004313   -
Depot tetracosactide
   Newcastle University
      2010   Phase 4   NCT01371526   United Kingdom;
Grapefruit Juice
   Haukeland University Hospital
      2008   -   NCT01271296   Norway;
HYDROCORTISONE SODIUM SUCCINATE
   Haukeland University hospital
      2010   -   EUCTR2009-010917-61-SE   Sweden;
Hydrocortison 100 mg (Pfizer®) in 2 ml solvent
   University Hospital of Wuerzburg
      2011   -   EUCTR2011-002687-25-DE   Germany;
Hydrocortisone
   EM-kliniken
      2006   -   EUCTR2005-001768-30-SE   Sweden;
   Haukeland University Hospital
      2013   Phase 2   NCT01847690   Norway;
   Oregon Health and Science University
      2000   -   NCT00688987   United States;
   Vastra Gotaland Region
      2014   -   NCT02152553   Sweden;
Hydrocortisone 100mg/ml
   The London Clinic
      2015   Phase 4   EUCTR2015-001090-40-GB   United Kingdom;
Hydrocortisone sodium phosphate
   University Hospitals Bristol NHS Foundation Trust
      2014   -   EUCTR2012-001104-37-GB   United Kingdom;
Hydrocortisonum
   Haukeland University hospital
      2010   -   EUCTR2009-010917-61-SE   Sweden;
Hydrokortison APL kapsel 2,
   Haukeland University hospital
      2010   -   EUCTR2009-010917-61-SE   Sweden;
Isocaloric Diet
   Oregon Health and Science University
      2000   -   NCT00688987   United States;
Liquorice
   Haukeland University Hospital
      2008   -   NCT01271296   Norway;
MabThera
   Newcastle upon Tyne Hospitals NHS Trust
      2008   Phase 4   EUCTR2007-003062-18-GB   United Kingdom;
Methylprednisolone
   Newcastle upon Tyne Hospitals NHS Foundation Trust
      2012   Phase 2   EUCTR2012-001682-33-GB   United Kingdom;
Rituximab
   Newcastle upon Tyne Hospitals NHS Foundation Trust
      2012   Phase 2   EUCTR2012-001682-33-GB   United Kingdom;
Solu-Cortef (hydrocortisone)
   Haukeland University Hospital
      2010   Phase 2/Phase 3   NCT01063569   Norway;Sweden;
Solu-Medrone
   Newcastle upon Tyne Hospitals NHS Foundation Trust
      2012   Phase 2   EUCTR2012-001682-33-GB   United Kingdom;
Solu-medrone
   Newcastle upon Tyne Hospitals NHS Trust
      2008   Phase 4   EUCTR2007-003062-18-GB   United Kingdom;
Synacthen Depot
   Newcastle upon Tyne Hospitals NHS Foundation Trust
      2012   Phase 2   EUCTR2012-001682-33-GB   United Kingdom;
      2010   -   EUCTR2009-018074-56-GB   United Kingdom;
Tetracosactide acetate
   Newcastle upon Tyne Hospitals NHS Foundation Trust
      2012   Phase 2   EUCTR2012-001682-33-GB   United Kingdom;